Kim I Cao

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

|Sep 28, 2023
Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience.

Jérémy Baude, Rémi Dendale, Kim Cao

|Apr 19, 2023
Protontherapy to maintain local control of head and neck paragangliomas.

Julie Chartier, Arnaud Beddok, Kim I Cao

|Sep 23, 2022
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases.

Judith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau

|Oct 13, 2021
Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression.

Amélie Aboudaram, Pierre Loap, Delphine Loirat

|Dec 23, 2020
Radiation therapy and immunotherapy in breast cancer treatment: preliminary data and perspectives.

Kim Cao, Louisa Abbassi, Emanuela Romano

Pageof 2

Frequent Collaborators

2 joint publications

Youlia M Kirova

1 joint publications

Amélie Aboudaram

1 joint publications

Adriana Langer

1 joint publications

Jérémy Baude